Editor's Note: Accuracy is not guaranteed; you can help us get better by highlighting mistakes and suggesting edits! Please fill out this survey if you wish to learn more about us and our mission or send me an email.
Listener supported WNYC Studios. Wait, you're OK? You're listening to Radiolab Radio from WNYC.
De de de de de moley Webster, I wonder how long it'll ring for Hey, I said, um, it rings for an awful long time before it makes, um.
How do I sound? You sound amazing. OK, great, because I'm in quite a contrived setup right now.
But are you in your closet under a blanket. Yeah. Got a desk, Mike, from the station after my mike that I ordered got stolen off my front porch. I want to do one thing. I'm going to take off my hat.
Give me a second, Mike. Down, off. I'm Jad Abumrad. This is Radiolab, that voice, of course, is Molly Webster. This is dispatch number three, which has to do with a bit of science that I feel really captures the spirit of this moment on so many levels.
We're going to tell you about that. And then second, we're going to play you an interview that. It's really kind of. Knocked us all on our butts. Great, OK, so I'm recording on this sense, so we've got a backup.
All right, Webster, are you did you get your two hour?
Do you mean my thirty five minute video?
OK, so we're in the we're in the just helter skelter mayhem of the last two weeks. Did you bump into this idea?
It was thinking about treatments basically because like the Holy Grail that everyone keeps talking about is a vaccine and thinking about how that vaccine, you know, the estimates are 12 to 18 months. And even in vaccine plan, that's pretty generous, like as far as a fast time scale goes. So, like, what happens in the interim time?
There are options on the table where they're like, hey, there's this drug that we've seen in the lab do well against coronaviruses in mice. Maybe we grab that drug and we try it here.
They're repurposing like rheumatoid arthritis drug treatments and they're repurposing drugs that they tried in the Ebola crisis but didn't work. But maybe they'll work here. Um, so there's actual stuff like that happening. But the thing that jumped out at me the most, probably because of its like immediacy and the potential for like now of using it now is blood transfusions and transfusions.
I don't even know what that means. Right. What does what does that mean? Because it has one more word in it. It's blood plasma transfusions. So suddenly you're like, what? What is a blood transfusion then? Like, what's plasma?
Maybe this is something you've seen mentioned in the press in the past couple of days. To my mind, when I hear the word blood transfusion, I think of those medical drawings from the seventeen hundreds where you see a tube running from one person's arm directly into another person's arm. The idea in this case in brief is that were, you know, standing in this tragic gap. Right.
This is what I talked about in the last dispatch. We know a little bit about this virus, but not nearly enough to be able to fight it effectively.
And we need to do something now. All the while, we do notice this difference that some people on their own seem to fight off the virus just fine, they have very mild symptoms.
Others get very, very sick. We don't yet understand why there's that difference. But maybe we could use it. The thought is, OK, if there's a coronavirus, if there's someone who had coronavirus and they survived, they survived because of some reason, like their body did something well and scared off this virus and crushed it and they lived. And so maybe if we tap into that body as a resource and take from it the thing, the part of it that fights off viruses, literally get it out of a survivor into a sick person, maybe we can save the sick person.
And so it's very crude.
It's super sounding super medieval. All of a sudden, the way that you're saying. I know. I know.
Like, what century are we living in? We don't really know why this works, but it kind of works. So just get that into the like.
And we know that it's, you know, safe in the sense that that blood was in another person. Like it's almost like you've already done a human trial. Like if you take my blood from me, it didn't hurt me. Right.
So I'm giving it to someone else and we'd be bad things in that blood.
Could there be like a could there be bad stuff? OK, let me explain how it works. So you would take somebody who has survived coronavirus, you would stick them in a chair, you would stick a needle in their arm and then you would take their blood, you would filter out the blood plasma, leaving behind the red blood cells in the white blood cells. You would take that plasma and you would put it into a patient who currently has coronavirus.
Now, what is plasma?
So, you know, plasma is the part of the blood that doesn't contain any living cells. So it doesn't have white blood cells, it doesn't have red blood cells, but it has the other stuff that makes up your blood. The thought is, is that the blood plasma is the part of the blood that holds anything that might have fought against an illness like the antibodies. Right. And so antibodies are the things that your body makes to fight an intruder.
So a virus comes in and we make an antibody to attack that virus. And then you have it's almost like your body makes its own drug.
So if I have survived the coronavirus, that means that for reasons that we don't really understand, I have some special drug in my blood plasma that can maybe help someone else fight it off, too.
Yeah, if you look at the different options that are out there, this has a good likelihood of working.
This is Arturo Casadevall. He's an immunologist at Johns Hopkins University. And he was really the first person in the states to say we should start doing this.
I I have been working on antibodies for my entire academic life, and I like history. And I I read a lot about the history of how antibodies were used.
This is not the first time we've thought about doing something like this. We've actually been doing it since the late 90s.
What was it used for initially, like in the 90s?
What was it like tuberculosis or they first used it for diphtheria?
I'm not sure I know what diptheria is here. Right. Let's look. I don't I couldn't actually dip Seria. I couldn't actually explain what the diptheria is. An infection caused by a bacterium. Diptheria causes a thick covering in the back of the throat. It can lead to difficulty breathing, heart failure, paralysis. And so they used it on that.
Yeah. And in that case, the serum didn't come from people. It came from horses.
Oh, yes. Did that work?
It did work. But then they realized you could do it with human blood too, by the way, was used in 1918.
That in the influenza epidemic. I wonder why they got that idea then. Oh, because it was known at the time that people who recover from infectious diseases made antibody that was known as the first Nobel Prize, by the way, in nineteen eighty one was given to anyone bearing for this for this discovery that you could transfer immunity. Oh, by transferring serum. Wow.
You know, they used it in the 20s for scarlet fever. They did it in a measles outbreak in Pennsylvania in the thirties. Seem to seem to stop an outbreak. So people got better. Oh yeah.
However, that practice was largely abandoned after 1950 for two reasons. One vaccine came on board. And the other thing was that they discovered blood in in some circumstances could carry infectious diseases.
Then you have an interesting thing where like the AIDS epidemic, you know, if you think about HIV, that's definitely pathogen and blood. So you see a bit of a pause and any blood story, you see a pause around, oh, that's really the AIDS crisis.
But then technology improves. We have so many ways of screening blood and screening blood really quickly. You start seeing them using it. And the SARS epidemic, it's been used. Murders that that that respiratory infection, which is a coronavirus, it's been used on other coronaviruses, basically.
So when I saw that this was happening and began to spread through the world, I knew that this could potentially be used. This could provide an option, obviously, you know, like any therapy, it needs to be tested.
And I reinforced that over and over again, that one needs to look at this as an experimental therapy as of this week, which is, you know, the second to last week in March, the FDA has given, like emergency approval to to both start investigating, like the plasma transfers, you know, with clinical trials and sort of, you know, scientific protocol.
But then they've also okayed it for compassionate use, which is that like if you have a case and they seem like they're failing, can you can you use it? You can now use it. That's what the FDA is saying. You now can use it.
And this is happening in New York, right? I mean, these are it's just starting. Yeah. So Mount Sinai in New York and Albert Einstein Medical College have said that they hope to start using it in patients on the ground the very beginning of April, essentially. And Arturo and the other scientists involved in this were saying one of the amazing things about doing the plasma transfers is you're going to find out really quick if it works, this isn't going to be one of those trials that requires years to be completed on.
So I think that there is a good likelihood that we that once you deploy this, that you will know whether it is working in a few weeks. But this is something that can can be tried today. OK, wow.
OK, so let's get getting back to this. OK, wait a second. Wait, wait a second. Wait, wait, wait. I pdl chill out. Chill out.
OK, let me look at mine. We're good. We're doing good. OK, so we were asked why.
Why isn't it been like like like ramped up at scale.
I mean there's no way for you to know this answer because there's not really a scale like it's like you have to find people who had the illness and you have to take their blood from them. And you have to make sure that blood is healthy, then if it is, you take their plasma from them and then you give it to someone else, that's really kind of like a one to one.
But that is interesting while because it's like maybe this is the I mean, OK, I'm just going to go wild with conjecture for a moment.
Maybe this is the scale moment because you have so many people who are infected and they're all in the same place and some of them are getting better magically and some of them aren't.
And so you have like the ability to do like a massive.
Yeah. Natural experiment, you know.
But the other thing is, is that so China's actually been doing this, I think, since January for their outbreak with with this covid-19.
And they've been doing transfusions.
They've been doing this serum transfusion. Yeah. Wow. And so and and the reports are that it's going well, though nothing's published yet. I mean, I guess I don't quite understand why it wouldn't work. It's like you take someone's blood that defeated the virus and you give to someone else. And it seems like, wouldn't it do the same thing?
So one of the problems with this type of therapy is that it works best. Early antibodies work best early in the course of disease.
And the question is, when is earlier and with covid-19? That's a tricky question, because often you have a viral count that's growing before you have symptoms.
And so so a lot of times people aren't even seeing people until it's like really bad.
So it makes it is a big difference between really bad and and the intensive care unit. Oh, OK, OK. And maybe this intervention and again, I stress that this would be a clinical trial. This is a hypothesis that needs to be tested. The administration of the Office of Plasma at that point of view may or may prevent progression of the disease so that people don't get into such trouble that they have to be on a respirator.
And so it looks like in the States they're going to break it down, like in New York, they're going to target like these three different groups. So they're going to target severe patients who really need help and are at risk of dying. They're going to target early patients who are just showing symptoms. And they're also they also want to use it prophylactically. So actually giving it to doctors and nurses who have no viral count, who are coronavirus negative and see if it can actually be a preventative.
And that's actually pretty cool.
I mean, it's really cool. That feels to me like. Wow, that feels to me like if they could do that, they should just do that. You know, I mean, I would take it now total and I'm in my closet. No, I know. I mean, I think about my sister in law who's a nurse is treating covid patients. And, man, if there's something that could help her, it's like, oh, yeah.
I mean, there's something kind of like just a pan out for a second. It's like as a paradigm. It's such an interesting, intimate way to treat because, I mean, these days, you know, like the whole. Field of medicine seemed to be moving toward little pills that you that you bew pop and you drink, do you take these pills and they they do something mysterious in your body and you feel better. This is so intimate and that it's one person having.
Suffered and survived. Then turning to the next person who's a few days behind them suffering and saying, let me help you. There's something very spiritual in a way about that.
Yeah, I find it. When Arturo and I were talking about on the phone, it felt very profound and like really beautiful in the sense that he talked about it as like sharing immunity, like we can pass immunity to each other.
And I thought, wow, sort of social distancing where we're all staying in our houses to protect. As many people as we can. That feels like such a golden gift, like like to be able to transfer something so profound to a person as like protection, it's like you can shepherd someone in it's like you can offer them safe passage.
But and it's it's it's safe passage.
It's such a metaphorical level.
It's the same feeling I get when I hear about people donating kidneys, you know, but this is this is somehow different because they've had it like it's one thing to just, like, give a donation.
It's another thing to say, like, I had this experience and I'm going to hold your hand through it. And I'm not physically holding your hand because none of us are allowed. But I'm like spiritually holding your hand because I'm giving you my blood and I'm and I'm helping you walk this path. I'm helping you take this journey. Coming up, we talk to somebody who, in a way, is taking that journey. That's after the break. Hi, my name is going to be alone and I'm currently quarantined in Champaign, Illinois, Radiolab supported in part by the Alfred P.
Sloan Foundation, enhancing public understanding of science and technology in the modern world. More information about Sloan Sloan, Doug.
Hello. Hi, is this Tatiana? Yes, it's OK. Hey, it's Mollie from Radiolab. How are you? I'm good. Can you hear me OK? Yeah, I can hear you fine. Can you hear me? I can. Yeah, there might be. There's like, Hey Dad, this is Radiolab.
We are back soon to play you. Now an excerpt of an interview that Molly did with someone who is right in the thick of this stuff.
So my name is Dr. Tatiana Prabal. I'm an internist and medical oncologist on faculty at Johns Hopkins and the breast cancer program.
And Molly ended up talking to Tatyana because of a tweet that she posted.
Can you tell me in your own words what the tweet was about and what it said? Sure.
So the tweet was about my brother in law's dad. We call him Papa Doc. He's actually an internist in California. I called him you know, I talked to my brother in law about something else, actually. And I just said, how's everybody? And he said, oh, my dad's a little under the weather. And I said, Wait, wait, how how's the under the weather? You know, he's eighty three. He's practicing medicine.
He's high risk. Right. And he said, oh well he's just been coughing a little bit. I don't think he's had fever or anything. And I literally said, I'm going to call him back. And I hung up and I called him and he said, Oh, I'm fine. I've just had a little bit of a cough, but I actually feel fine. I'm not short of breath at all. And his wife volunteered. Yeah, he seems fine.
He looks fine. He's just been napping more than usual. Normally he doesn't just nap during the day and he's been napping. He's been falling asleep on the couch and so forth. And I said, all right, that's it. You guys are going to urgent care right now. I think you're hypoxic. I think your oxygen level is low. They thought I was being crazy and I said, we're just going to talk about one thing for you go.
And that is whether or not you are willing to be intubated. And he actually laughed. He was like, I just have this dry cough, like, why are we talking about a ventilator? And I just said, I'm worried about you because you're falling asleep inappropriately and you're eighty three and you're a doctor, which means I'm sure you've been exposed to these patients. And he said, yes, you think I to do that. And I just said, listen, you know, we can support you, but you have to go right now because I think you have covid-19 and he went to the urgent care straight from that call.
He hung up. He went his oxygen saturation was 92 percent. It should be one hundred percent. They sent him directly from there to the E.R. and he has covid-19 illness and has been hospitalized now for a little over a week and is in their intensive care unit in a community hospital, in fact, the same community hospital where he was on staff for many decades. And so my tweet was asking if there was anyone who had had covid-19 and recovered and who was interested in serving as a potential donor of plasma in Southern California, where he's currently hospitalized.
And how did you I mean, I guess your doctor so maybe you're in the zone, but you're about to tell me, like, how did you know even to think about asking for plasma or like think like maybe he could get a plasma transfusion?
Yeah, I think it's a mix of things. So one is that I'm on faculty at Johns Hopkins and as I believe, you know, a lot of the work that is going on with convalescent plasma has been centered there. And the other thing is that my husband is an infectious diseases physician in the Navy. And so and he's actually a family where we've been bouncing a lot of ideas back and forth about how best to take care of people with this.
And of course, this is not a new concept. You know, no one just got the idea to give convalescent plasma right at this moment. For the first time, this has been done going back more than one hundred years. And it's a way, honestly, for people who've experienced this illness and recovered to contribute at a time that I feel like. The public really wants to contribute. You know, I think that that's a thing I sent so much from my friends and family and neighbors and everyone who's not in medicine is they're all they're all rooting for us who are in science and medicine, but they're all at the same time feeling kind of like they want to they want to do something.
They have this restlessness. Everybody's quarante and everybody's kids are home. They're watching the news or they're watching social media and they're feeling like this catastrophe is unfolding and they're just sitting there. I think that I think that there is this sense that we're at war and the war is being fought by a very small number of people. There will be millions of cases in the US before this is over, millions and millions and not all of those people will be qualified to donate plasma, but many of them will.
And so it's a great opportunity.
I have to like I'm like, what happened with your tweet?
But did you give blood so oh, gosh, well, I tweeted that late at night, I can't recall a time it was, but it was it was late and honestly, I didn't expect it would get a lot of attention. And within minutes, I had hundreds of people commenting, retweeting private messaging, me, telling me this is my blood type. You know, this is how many days ago I was sick. Where exactly do you need me to go?
Which day I can see if I can get off of work. I mean, people just really came out of the woodwork. I had people messaging me with a with a PDF of their their test results to show me what day it was positive. I mean, I just got all kinds of stuff and they were suddenly not just contacting me as a donor. Suddenly people realized, oh my gosh, there are hundreds of people that want to donate. My family member needs plasma.
So then suddenly I had people messaging me saying we're looking for plasma help. Like, have you gotten anyone who's in New York? Have you gotten anyone who's in Louisiana? Do you have anyone who's this blood type? So suddenly I was sitting on my bed trying to match these people up, and I spent pretty much three days in my Tamás on my bed trying to match people up. It became, you know, complex because it's really impractical. Right.
That's not the way that you are only one person. Exactly.
I mean, how did you feel like having the weight of all of this on you? Like, were you like, am I going to find a donor? Am I not going to find a donor? People think I'm going to find a donor. And what if I don't? I want to save this, but I can't.
You know, I think I was always I was always confident that we'd find somebody.
How come? Well, a few things, one is I'm an oncologist and you talk to a handful of oncologists, I think I think that you discover instantly is that oncologists are really optimists, like deeply optimistic people. Certainly oncologists of a certain age. And I put myself in that category. I'm forty seven. I think anybody who's been doing oncology for 10 or 15 or 20 years. It has to be an optimist because we were taking care of people with cancer when the treatments were really not very effective and a lot of cases, you know, we lost a lot of people and you really have to, I think, come into it every day with the attitude of I may be able to say to save this person.
I think the other thing, though, is just a kind of an understanding of statistics. I mean, it's a pandemic, right? It grows exponentially. The number of cases are are doubling every three days or something. So I realized, you know, the same way that it didn't take very long for this this outbreak to get completely out of hand and essentially closed down the world. It also wasn't going to take very long for me to have a really large number of qualified donors who were had been infected and recovered.
Did he. Did you find a match? Did you. Online, we did actually find a match. And his we just found a match. And the person lives a few hours away from where my papa doc is hospitalized. He actually has the same first name as one of the patient's sons, which was they felt was very symbolic. And so the services and transfusion is supposed to happen tomorrow, Tuesday.
Wow. So last question. What do the next couple of days look like for you in the case of Papa Doc?
Yeah. So he you know, he's his donor is coming tomorrow and the the blood drive will happen and then that plasma will be tested and processed and transfused into him tomorrow with the expectation. And then we wait and we see you know, I think that we're hoping that that it will help him clear the virus pretty quickly. That's the hope.
Yeah. I think that having an infection, maybe even being critically ill from it, recovering and then saying, I know how awful that was, how scary that was, how how absolutely uncertain everything felt when I was sick and I have the capacity to be myself, I can go give plasma. And if I give a plasma donation, like a plasmapheresis donation where they take off three and it's a plasma, I can treat three people with this. That's it.
Because, you know, it's interesting. Every virus has a number that we call are not like our Sub-Zero, are not is how it's pronounced. And that number is how many people an average infected person will themselves infect. So if you look at, you know, some of our less contagious things like seasonal flu that are closer to one, if you look at Spanish flu, it was about two or a little more than two. So each person who got infected on average gave two other people the infection.
And this this virus, sars-cov-2, is closer to three. So that means everybody on average who's got it is going to give it to three other people. So it feels kind of cool, like there's some sort of order in the universe that each person who gets it, who donates plasma can actually treat three people. Wow.
I didn't realize it was three. I thought it was at most two. Yes, three. And I just the you know, the the what do I call it? I don't know what the symmetry of that in the universe that they are not for this virus is three. And the number of people that a plasma donor can treat after they've been infected is three. It just feels like. I don't know, there's something beautiful about that. Well, you've given me a lot to think about and also just feels so good to just, like, share thoughts and ideas.
So thank you for for that. Sharing your own and listening and responding back and stuff like sort of in the middle of all this crazy.
Oh, yeah. No, listen, that's the humanity in it, right? Like, that's the if something good comes from all this, it's that we kind of just distill down like like all the all the unnecessary stuff is gone. Right. Like what's left is what really matters. Like you're down to do we have sufficient nutrition to keep our bodies going. Are we with the people that we love most and are they safe? Are we able to do our most essential work, even if it's hard and it's made more complex?
You know, like we really I mean, that is that is the little tiny, tiny pearl at the center of all this is that it forces us to say what is essential. And part of that essential ness is connecting with other people meaningfully, deeply. You know, that is a big part of it. The thing the greatest tragedy in my mind of this entire illness, which we didn't touch on at all, is the fact that people die alone.
Yeah. So, you know, in the case of pop attack, a thing that has been really hard for our family was they sent him directly to the E.R. and his wife called me and said we went there and they heard what his oxygen level was and that he had been coughing and that he was a physician. And they took him right back into the isolation area as a PR person under investigation for covid-19. And they won't let me come in to the E.R. because I'm not symptomatic and they don't want me to be exposed and I can't be with him because he's now in this isolation unit.
And that's the last time she saw him. Like, she literally pulled up to the E.R. and he went in and she's never seen him again. And if he died, she'd never see him alive again. And that is. The greatest tragedy, there's going to be so much tragedy from this, right? We're going to lose so much life. We're going to lose life of people that are on the front lines as first responders and as physicians and nurses.
And we're going to lose people who are young. But I think that amidst all that other tragedy, the biggest tragedy is going to be. That hundreds of thousands or millions of people before this is over will die alone. In many cases, these patients aren't even attended by a physician when they're dying, you got you have a phone call with them from outside the room. You only go in the room if you need to lay hands on the patient to do a procedure or something.
These people are going into the hospital. They walk into the E.R., they're coughing or something. And they don't know. They don't realize. I didn't even realize. I mean, I realized, but I didn't think of it. I knew if he went in there that he would immediately be put into a room as a person under investigation. But I didn't. It happened so fast that I didn't say, like, tell him you love him. Like, spend 10 minutes in the car before you send him in.
You've been we've been living with him for weeks. Like you've been exposed like take ten minutes. He's not critically ill. Take ten minutes and talk to each other, say what you need to say, tell him the logistics stuff like whatever you need to do, like do it. And I didn't think to do that. And I'm a physician. I knew that these people are being isolated. It didn't occur to me. But for somebody who doesn't realize that they drive their family member up to the E.R. and that's it, the people who die, they'll never laid eyes on them again.
You know, I think a lot about death, I've attended a lot of death as an oncologist, a lot like I can't I've been a doctor for 21 years and I've been an oncologist for, gosh, seven, 10 of those eight. Six of those are something a lot of a lot of years. I can't even begin to guess how many deaths I've pronounced I've. Then a witness to death a lot of times and. There are a lot of things that distinguish a good death from a bad death, you know, being free of pain and having closed all your loops, you know, not feeling like you're dying with unfinished business on either side on the part of the person who's dying or on the part of the survivors.
Like that's the thing. You know, if you're prepared, if you aren't surprised by death, those are the people that have a good death. You know, I think there's just some sort of peace and resolution in the end of suffering. These deaths are the exact opposite of that. It is the worst death. No one's prepared for it. No one has closed the loop. No one got the logistics ready. No one did the emotional hard work of making sure that everyone said what they need to say and people have forgiven whom they need to forgive.
And none of that's done. I don't know, it's a lot to. It's a lot to think about people dying alone. I stole their. Hello. Hello. That was such a dramatic ending. I'm so sorry. I know, I know. I think that that's how you should end it, actually.
I just that's that's like the universe telling you that you've got isolated in the end while talking about end of isolation.
And I was like, I can hear you and I can feel you. And I have like tears in my eyes and this is deeply moving there. Or some reason my microphone is not working.
That's the universe telling you. That's the end of that show. Oh, that's that's it. Well. Yeah, it's a lot. I so appreciate you, thank you. Well, I I definitely want you to get back to saving people's lives, though, think like that. And all these texts while we've been talking, actually, I was just looking I had to send another person while we've been. Well, you called me back. I am.
Oh, sorry. Actually, hang on. This is actually poppadoms, doctor. Go, go, go. Bye bye. Bye bye.
What a crazy experience. We checked in with Tatiana after that conversation, Papa Doc had his transfusion on Wednesday night. As of Thursday night, when we finish this podcast, he was still in the ICU, still on a ventilator, hanging on. We will let you know more when we find it out. So I want to stress that there are a lot of people working on this right as we speak, and what I do, what I can tell you is to be current working criteria is that we're going to wait two weeks, two weeks until the symptoms stop.
Then at that point, you test them for the virus and make sure the virus is really gone. And then you ask them to donate blood and then you look for antibodies from the blood and those people with high antibody become donors. If you've had covid-19 and recovered and you'd like to donate plasma, go to our website, radio lapdog. We've compiled a bunch of resources there for you. We tried to make it as clear as possible. You can also go to the website of the American Red Cross.
That's Red Cross Blood Dog, Red Cross, Blood Dog. To find out more information there. If you're in New York City, check out New York Blood Center to figure out how to donate. Special thanks for this episode to Evan Bloch and Dr. Tim Bion. And Jad Abumrad, thank you all for listening. Stay safe. Keep taking care of each other. Hi, this is Jamie A. calling from Woodland Park, New Jersey. Radiolab is created by Jad Abumrad with Robert Krulwich and produced by Sean Wheeler.
Dylan Keefe is our director. John Lichtenberg is our executive producer. Our staff includes Simon Adler, Becca Gressler, Rachel Kucik, David Kebbel, Bethel Habchi, Tracy Hunt, Matt Kielty, Danny McHugh and Lateef Nasher Sharecare Harian Whack Pat Walters and Molly Webster with help from Cima Alaei, W. Harry Fortuna Steinbeck, Melissa O'Donnell, Cadd Davis and Russell Gregg. Our fact checker is Michelle Harris.
So hi, my name is Anna McKewon, I'm a producer at Radiolab, and I wanted to talk about this thing we do at Radiolab because I like it. We have this thing. It's a newsletter, big surprise. Every show has a newsletter, but ours, I think it's pretty fun.
Oh, it's so fun. Matt, KDDI. Hello, producer Pheidippides at Radiolab.
What is your favorite part of the newsletter?
My favorite part of the newsletter is first it's getting it and seeing it in my inbox and then second, it's opening it and then third is just hitting page down on my keyboard till I get to the very bottom of the email.
You know, it's at the bottom of the email where, you know, staff picks stuff fix at the bottom, which is like, how great is that? It's great. Just like stuff. Stuff that we like. Stuff for India. What are your favorites? Some of his stuff. There was the one video where it was like seventeen babies on a hamster wheel. Really the article about the guy who ate seventeen burritos.
Nothing. Real ones. OK, what's your favorite stuff. My favorite one ever. Well it's hard to say.
One of my favorite ones ever was Robert talking in delightful detail about the great sausage duel of 1865, classic classic Mollie's bedbug pajamas.
That was a scary time treacy's pasta recipe, which I did not make because I don't really cook, but I'm just proud of her. Actually, it's it's really simple. This is online.
It's a twenty eight ounce can tomatoes, five tablespoons of butter, a pinch of salt, an onion, and you cook it in a pan for 45 minutes. All right.
Thank you, Tracy. I'm telling you, everybody is loving this positive. Oh, I do. Definitely. That woman. This guy for sure. I think it's wonderful tasting pasta every day.
Yeah, helping. Anyway, a newsletter as like cools off in it, like staff picks. It also tells you when an episode is dropping, it's free. It's free. Um, so we're just kind of here to just say, like you should sign up and you can sign up in about 30 seconds at real iboga newsletter or text RL News, as in radio news, two seven zero one zero one. That's our little news two seven zero one zero one.
And thank you.